At a Glance
Finasteride is a selective 5-alpha reductase inhibitor approved for benign prostate hyperplasia (BPH) and male pattern baldness. It's widely used in men's optimization to reduce DHT conversion and mitigate testosterone-related side effects, but post-finasteride syndrome remains a recognized concern, and psychiatric side effects (depression, anxiety, suicidal ideation) are now included on regulatory labels.
What It Is
Finasteride is a 5-alpha reductase inhibitor that blocks the conversion of testosterone to dihydrotestosterone (DHT), the more potent androgen in prostate and scalp tissue. Available in two formulations: Proscar (5 mg for BPH) and Propecia (1 mg for hair loss).
How It Works
Finasteride selectively inhibits type II 5-alpha reductase, the enzyme predominant in prostate, scalp, and other androgen-sensitive tissues. By reducing DHT, it reduces prostate volume and slows male pattern baldness. It does not significantly affect circulating testosterone levels but reduces serum DHT by approximately 70% and prostatic DHT by up to 90%.
Key Benefits
- Reduces prostate volume and improves urinary symptoms in BPH
- Slows or stabilizes male pattern hair loss; some regrowth possible
- Mitigates acne and oily skin during testosterone therapy
- Well-tolerated with low incidence of systemic side effects in most men. IMPORTANT: Finasteride is FDA Pregnancy Category X — absolutely contraindicated in pregnancy. Women who are or may become pregnant must not handle crushed or broken tablets.
- Generally well-tolerated at the 1 mg dose for hair loss
Who It's For
- Men with benign prostate hyperplasia seeking non-surgical treatment
- Those with male pattern baldness interested in slowing or reversing hair loss
- Men on testosterone therapy experiencing prostate-related side effects
- Individuals with DHT-sensitive conditions (acne, male pattern baldness)
Typical Use
Typical hair loss dosing is 1 mg daily; BPH dosing is 5 mg daily. Most men use finasteride long-term to maintain benefit; discontinuation typically results in return of baseline symptoms within 12 months.
Important Safety Information
- Sexual side effects (decreased libido, erectile dysfunction, ejaculatory disorders) are reported in approximately 2–8% of men in clinical trials, usually reversible upon discontinuation, though persistent sexual dysfunction has been reported in some cases and is acknowledged on regulatory labels
- Psychiatric side effects including depression, anxiety, and suicidal ideation/behavior have been reported and are included on FDA, EMA, and MHRA labels. Post-finasteride syndrome (persistent sexual, neurological, and psychiatric effects after discontinuation) is reported and remains under active regulatory review
- Reduces PSA levels by ~50%; PSA screening requires adjustment for finasteride use. Note: The Prostate Cancer Prevention Trial found finasteride may increase the risk of high-grade prostate cancer (FDA label warning). Hypersensitivity to finasteride is a contraindication.
- Finasteride is FDA Pregnancy Category X — contraindicated in women who are or may become pregnant. Women must not handle crushed or broken tablets due to risk of absorption. Men should not donate blood during treatment or for at least one month after discontinuation
Global Regulatory Status
Note: Finasteride is globally approved and well-established, though regulatory bodies are actively reviewing its psychiatric safety profile (EMA Article 31 referral 2024; MHRA Drug Safety Update 2024).
The Bottom Line
Finasteride is an effective, well-established agent for BPH and male pattern baldness. Most side effects are reversible upon discontinuation, though persistent sexual, neurological, and psychiatric effects have been reported in a minority of users and are now acknowledged on regulatory labels.
This guide is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any supplement or medication.